col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


26 Ergebisse       Seite 1

 [1] 
Informa UK (Taylor & Francis): Journal of Enzyme Inhibition and Medicinal Chemistry
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2026―Jan―02 Insights into the complexity of SARS-CoV-2 M pro inhibition: Ebselen and its derivatives impair dimerisation of the enzyme Simone Fabbian, Silvia Fabi, Laurin Schwarz, Giovanni Preto, Chiara Schiavinato, Cristiano Salata, et al. (+4)
2 [GO] 2025―Nov―17 Discovery of benzyl carbamate inhibitors of coronavirus M pro enzymes from a legacy collection of cysteine protease inhibitors Mateus Sá Magalhães Serafim, Thales Kronenberger, Karol R. Francisco, Erik Vinicius de Sousa Reis, Ellen Gonçalves de Oliveira, Fernanda Kelly Marcelino e Oliveira, et al. (+14)
3 [GO] 2025―Mai―21 Identification of broad-spectrum M pro inhibitors: a focus on high-risk coronaviruses and conserved interactions Man Liu, Li Zhao, Xupeng Huang, Zhenhao Tang, Yihang Zhong, Mengrong Yan, et al. (+9)
4 [GO] 2025―Mai―15 Natural product sennoside B disrupts liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein by inhibiting its RNA-binding activity Da-Wei Zhang, Xiao-Shuang Xu, Liangxu Xie, Lei Xu, Zhiguo Fu, Yimin Li, Xiaojun Xu
5 [GO] 2025―Feb―06 Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds Noor Atatreh, Radwa E. Mahgoub, Mohammad A. Ghattas
6 [GO] 2024―Aug―29 Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus Cong Wu, Qi Jiang, Hui Zhong, Xudong Zhou, Leping Liu, Tong Pan, et al. (+3)
7 [GO] 2024―Aug―20 In-cell bioluminescence resonance energy transfer (BRET)-based assay uncovers ceritinib and CA-074 as SARS-CoV-2 papain-like protease inhibitors Mei Li, Zhu-Chun Bei, Yongtian Yuan, Baogang Wang, Dongna Zhang, Likun Xu, et al. (+3)
8 [GO] 2024―Jan―15 Identification and evaluation of antiviral activity of novel compounds targeting SARS-CoV-2 virus by enzymatic and antiviral assays, and computational analysis Ivana Nemčovičová, Katarína Lopušná, Iveta Štibrániová, Fabio Benedetti, Federico Berti, Fulvia Felluga, et al. (+17)
9 [GO] 2023―Dez―14 Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19 Karol Biernacki, Olga Ciupak, Mateusz Daśko, Janusz Rachon, Damian Flis, Justyna Budka, et al. (+4)
10 [GO] 2023―Dez―13 Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies Zorana Ferjancic, Filip Bihelovic, Bojan Vulovic, Radomir Matovic, Milena Trmcic, Aleksandar Jankovic, et al. (+10)
11 [GO] 2023―Aug―28 The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication Elisa Bianconi, Anna Gidari, Maria Souma, Samuele Sabbatini, Deborah Grifagni, Carlo Bigiotti, et al. (+6)
12 [GO] 2023―Aug―22 Peptide foldamer-based inhibitors of the SARS-CoV-2 S protein-human ACE2 interaction Violeta Marković, Jeelan Basha Shaik, Katarzyna Ożga, Agnieszka Ciesiołkiewicz, Juan Lizandra Perez, Ewa Rudzińska-Szostak, Łukasz Berlicki
13 [GO] 2023―Jul―12 Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease Mai H. ElNaggar, Abdullah A. Elgazar, Ghada Gamal, Shimaa M. Hamed, Zainab M. Elsayed, Mohamed K. El-Ashrey, et al. (+7)
14 [GO] 2022―Okt―28 Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings Jie Dong, Mihayl Varbanov, Stéphanie Philippot, Fanny Vreken, Wen-bin Zeng, Vincent Blay
15 [GO] 2022―Aug―09 Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication Jerneja Kladnik, Ana Dolinar, Jakob Kljun, David Perea, Judith Grau-Expósito, Meritxell Genescà, et al. (+3)
16 [GO] 2022―Aug―01 Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, Noura M. Abo Shama, Eman Y. Santali, Bahaa Elgendy, Ahmed A. Al-Karmalawy
17 [GO] 2022―Jun―13 From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19? Matteo Pavan, Davide Bassani, Mattia Sturlese, Stefano Moro
18 [GO] 2022―Apr―14 Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)? Matteo Pavan, Davide Bassani, Mattia Sturlese, Stefano Moro
19 [GO] 2022―Jan―11 Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors  Mahmoud A. El Hassab, Wagdy M. Eldehna, Sara T. Al-Rashood, Amal Alharbi, Razan O. Eskandrani, Hamad M. Alkahtani, et al. (+2)
20 [GO] 2021―Jul―22 Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332 Matteo Pavan, Giovanni Bolcato, Davide Bassani, Mattia Sturlese, Stefano Moro
21 [GO] 2021―Jun―10 Of mitochondrion and COVID-19 Khalid Omer Alfarouk, Sari T. S. Alhoufie, Abdelhameed Hifny, Laurent Schwartz, Ali S. Alqahtani, Samrein B. M. Ahmed, et al. (+10)
22 [GO] 2021―Jun―02 Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection? Secil Deniz, Tugba Kevser Uysal, Clemente Capasso, Claudiu T. Supuran, Ozen Ozensoy Guler
23 [GO] 2021―Mrz―09 In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches Mahmoud A. El Hassab, Tamer M. Ibrahim, Sara T. Al-Rashood, Amal Alharbi, Razan O. Eskandrani, Wagdy M. Eldehna
24 [GO] 2021―Jan―25 Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro Hongbo Liu, Fei Ye, Qi Sun, Hao Liang, Chunmei Li, Siyang Li, et al. (+4)
25 [GO] 2021―Jan―14 Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors Wei-Chung Chiou, Meng-Shiuan Hsu, Yun-Ti Chen, Jinn-Moon Yang, Yeou-Guang Tsay, Hsiu-Chen Huang, Cheng Huang
26 [GO] 2020―Aug―04 Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro Seri Jo, Suwon Kim, Dae Yong Kim, Mi-Sun Kim, Dong Hae Shin
 [1] 

26 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.003 sec